Should we give anti-D immunoglobulin to Rh-negative women with first trimester bleeding?

MOspace/Manakin Repository

Breadcrumbs Navigation

Should we give anti-D immunoglobulin to Rh-negative women with first trimester bleeding?

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/14863

[+] show full item record


Title: Should we give anti-D immunoglobulin to Rh-negative women with first trimester bleeding?
Author: Paddock, Elizabeth; Carlson, Jensena
Keywords: alloimmunization
Kleihauer-Betke test
fetomaternal hemorrhage
Date: 2012-08
Publisher: Family Physicians Inquiries Network
Citation: Evidence Based Practice 15(8): 05.
Abstract: Little solid evidence exists for or against the use of anti-D immunoglobulin (RhIG) in women with first trimester bleeding who have a viable intrauterine pregnancy. Both the benefits of administering RhIG (a theoretical reduction of alloimmunization) and potential harms (other than the known cost) are likely small. Guidelines conflict on their recommendations.
URI: http://hdl.handle.net/10355/14863

This item appears in the following Collection(s)

[+] show full item record